BiotechTube
Home/Context Therapeutics/Martin Lehr
ML

Martin Lehr

Chief Executive Officer

Context Therapeutics

Therapeutic Areas

OncologySolid Tumors

Context Therapeutics Pipeline

DrugIndicationPhase
CTIM-76Advanced Solid Tumors (e.g., Ovarian, Testicular)Phase 1
CT-95Advanced Solid Tumors (e.g., Mesothelioma, Ovarian, Pancreatic)Phase 1
CT-202Advanced Solid Tumors (e.g., Urothelial, Breast)Phase 1

Leadership Team at Context Therapeutics

KC
Karen Chagin, MD
Chief Medical Officer
JM
Jennifer Minai-Azary, CPA
Chief Financial Officer
AL
Alex Levit, Esq
Chief Legal Officer
CB
Christopher Beck, MBA
SVP of Operations
JD
Jennifer Dashnau, PhD, MBA
SVP Technical Operations
BH
Bruce Hug, MD, PhD
VP Clinical Development
AP
Andy Pasternak
Chairman, Independent Director
PK
Philip Kantoff, MD
Independent Director
View full Context Therapeutics profile